Use of Ozone-Depleting Substances; Removal of Essential Use Designations; Confirmation of Effective Date
other · Food and Drug Administration · Rule · Published 2007-04-27 · Effective 2007-04-23 · 72 FR 20942
Document
Document number
E7-8043
Federal Register citation
72 FR 20942
CFR reference
21 CFR 2
Type
Rule
Action
Direct final rule; confirmation of effective date.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2007-04-27
Effective date
2007-04-23
HHS docket
Docket No. 2006N-0416
Abstract
The Food and Drug Administration (FDA) is confirming the effective date of April 23, 2007, for the direct final rule that appeared in the Federal Register of December 7, 2006 (71 FR 70870). The direct final rule amends the regulation to remove beclomethasone, dexamethasone, fluticasone, bitolterol, salmeterol, ergotamine tartrate, and ipratropium bromide, used in oral pressurized metered- dose inhalers, from the list of essential uses of ozone-depleting substances. None of these products is currently being marketed. This document confirms the effective date of the direct final rule.